The aim of this study was to compare sequelae and acute kidney injury (AKI) occurrence among patients with necrotizing enterocolitis (NEC) after changing institutional guidelines replacing vancomycin with ampicillin for gram-positive coverage. This was a retrospective, single-center cohort analysis of patients from 2016-2020 (n = 73) with NEC at a surgical neonatal intensive care unit with a high community prevalence of methicillin-resistant Staphylococcus aureus (MRSA). Multivariate logistic regression was utilized to assess associations. Twenty-five (34%) patients had at least 1 sequela related to NEC. Ampicillin containing regimens were not associated with any sequelae type or AKI. Postmenstrual age < 29 weeks at diagnosis ([OR] 5.8 [1.2–28.8], P = .03; and receipt of vasopressors [OR] 3.3 [1.1-10.2], P = .04) were independently associated with sequalae. Stage III NEC was independently associated with AKI, OR 10.6 (2–55.6), P = .005. In conclusion, ampicillin-containing regimens are effective for NEC management at our institution despite a high prevalence of MRSA.
StollBJHansenNIBellEF, et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012. JAMA. 2015;314(10):1039-1051. doi:10.1001/jama.2015.10244.
2.
FitzgibbonsSCChingYYuD, et al. Mortality of necrotizing enterocolitis expressed by birth weight categories. J Pediatr Surg. 2009;4(6):1072-1075; discussion 1075-1076. doi:10.1016/j.jpedsurg.2009.02.013.
3.
HanSMHongCRKnellJ, et al. Trends in incidence and outcomes of necrotizing enterocolitis over the last 12 years: a multicenter cohort analysis. J Pediatr Surg. 2020;55(6):998-1001. doi:10.1016/j.jpedsurg.2020.02.046.
4.
HodzicZBolockAMGoodM.The role of mucosal immunity in the pathogenesis of necrotizing enterocolitis. Front Pediatr. 2017;5:40. doi:10.3389/fped.2017.00040.
5.
NiñoDFSodhiCPHackamDJ.Necrotizing enterocolitis: new insights into pathogenesis and mechanisms. Nat Rev Gastroenterol Hepatol. 2016;13(10):590-600. doi:10.1038/nrgastro.2016.119.
6.
CanteyJBPyleAKWozniakPSHynanLSSánchezPJ.Early antibiotic exposure and adverse outcomes in preterm, very low birth weight infants. J Pediatr. 2018;203:62-67. doi:10.1016/j.jpeds.2018.07.036.
7.
GuilletRStollBJCottenCM, et al. Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics. 2006;117(2):e137-e142. doi:10.1542/peds.2005-1543.
8.
CarloWFKimballTRMichelfelderECBorderWL.Persistent diastolic flow reversal in abdominal aortic Doppler-flow profiles is associated with an increased risk of necrotizing enterocolitis in term infants with congenital heart disease. Pediatrics. 2007;119(2):330-335. doi:10.1542/peds.2006-2640.
9.
PatelRMKnezevicAShenviN, et al. Association of red blood cell transfusion, anemia, and necrotizing enterocolitis in very low-birth-weight infants. JAMA. 2016;315(9):889-897. doi:10.1001/jama.2016.1204.
10.
CaplanMSMacKendrickW.Inflammatory mediators and intestinal injury. Clin Perinatol. 1994;21(2):235-246.
11.
KliegmanRMFanaroffAA.Necrotizing enterocolitis. N Engl J Med. 1984;310(17):1093-1103. doi:10.1056/NEJM198404263101707.
12.
BellMJTernbergJLBowerRJ.The microbial flora and antimicrobial therapy of neonatal peritonitis. J Pediatr Surg. 1980;15(4):569-573. doi:10.1016/s0022-3468(80)80775-5.
13.
BrookI.Microbiology and management of neonatal necrotizing enterocolitis. Am J Perinatol. 2008;25(2):111-118. doi:10.1055/s-2008-1040346.
14.
BuryRGTudehopeD.Enteral antibiotics for preventing necrotizing enterocolitis in low birthweight or preterm infants. Cochrane Database Syst Rev. 2001;2001(1):CD000405. doi:10.1002/14651858.CD000405.
15.
SolomkinJSMazuskiJEBradleyJS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis. 2010;50(12):1695. doi:10.1086/649554.
16.
LeeKRBaggaBArnoldSR.Reduction of broad-spectrum antimicrobial use in a tertiary children’s hospital post antimicrobial stewardship program guideline implementation. Pediatr Crit Care Med. 2016;17(3):187-193. doi:10.1097/PCC.0000000000000615.
17.
MurphyCNairJWrotniakBPolischukEIslamS.Antibiotic treatments and patient outcomes in necrotizing enterocolitis. Am J Perinatol. 2020;37(12):1250-1257. doi:10.1055/s-0039-1693429.
18.
AutmizguineJHornikCPBenjaminDKJr, et al. Anaerobic antimicrobial therapy after necrotizing enterocolitis in VLBW infants. Pediatrics. 2015;135(1):e117-e125. doi:10.1542/peds.2014-2141.
19.
Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Inter Suppl. 2012;2:1-138.
20.
ZaoutisTEPrasadPALocalioAR, et al. Risk factors and predictors for candidemia in pediatric intensive care unit patients: implications for prevention. Clin Infect Dis. 2010;51(5):e38-e45. doi:10.1086/655698.
21.
ScheifeleDWGinterGLOlsenEFussellSPendrayM.Comparison of two antibiotic regimens for neonatal necrotizing enterocolitis. J Antimicrob Chemother. 1987;20(3):421-429. doi:10.1093/jac/20.3.421.
22.
CrissCNSelewskiDTSunkaraB, et al. Acute kidney injury in necrotizing enterocolitis predicts mortality. Pediatr Nephrol. 2018;33(3):503-510. doi:10.1007/s00467-017-3809-y.
23.
BakhoumCYBasalelyAKoppelRISethnaCB.Acute kidney injury in preterm infants with necrotizing enterocolitis. J Matern Fetal Neonatal Med. 2019;32(19):3185-3190. doi:10.1080/14767058.2018.1459553.
24.
RybakMJAlbrechtLMBoikeSCChandrasekarPH.Nephrotoxicity of vancomycin, alone and with an aminoglycoside. J Antimicrob Chemother. 1990;25(4):679-687. doi:10.1093/jac/25.4.679.
25.
GoetzMBSayersJ.Nephrotoxicity of vancomycin and aminoglycoside therapy separately and in combination. J Antimicrob Chemother. 1993;32(2):325-334. doi:10.1093/jac/32.2.325.
